Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
59.70
+0.64 (+1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
January 11, 2023
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.
Via
Benzinga
Exact Sciences Corp Stock Price Is Trending Up Here's Why
January 10, 2023
Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter.
Via
MarketBeat
Exact Sciences Breaks Up From This Pattern, Signals Massive Reversal: Is A Bull Cycle In The Cards?
January 09, 2023
Exact Sciences Corp (NASDAQ: EXAS) gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50.
Via
Benzinga
Exact Sciences Raises Fourth-Quarter Estimates Above Expectations
January 09, 2023
EXAS stock jumped Monday as the provider of cancer screening and diagnostic tests raised estimates for its fourth quarter.
Via
Investor's Business Daily
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
January 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
What's Going On With Exact Sciences Stock?
January 09, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Monday after the company announced preliminary fourth-quarter results.
Via
Benzinga
NYSE Exec: There's 1 Stock In Cathie Wood's Fund That's Ready To Rise (It's Not Tesla)
January 05, 2023
As of Thursday, the ARK Innovation ETF (ARCA: ARKK) held 31 stocks. But there's only one name in the entire basket that appeals to Jay Woods, chief market strategist at Drive Wealth and NYSE executive...
Via
Benzinga
Hey, Tesla Investors! Cathie Wood Is Betting on TSLA Stock (Again).
January 04, 2023
Cathie Wood is still betting big on TSLA stock, adding even more shares. Here's what investors need to know about the future of Tesla.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
January 02, 2023
In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks.
Via
Benzinga
Cathie Wood Says Risk-Off Environment Pushed Investors Back Toward Benchmarks: 'While Innovation Solves Problems...'
December 28, 2022
Cathie Wood has acknowledged in her year-end newsletter that a risk-off market environment has pushed investors back toward benchmarks during the last two years, disadvantaging strategies that focus on...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Are Growth Investors Finally Cutting Ties With Cathie Wood? Ark Innovation Flows Vanish As Flagship Fund Hits 5-Year Low
December 20, 2022
ARK Innovation ETF (ARCA: ARKK) hit new five-year lows on Tuesday, led by declines in the top holdings of Ark's flagship fund.
Via
Benzinga
Which Is the Better Buy: Vertex or Invitae?
December 16, 2022
Is Vertex worth its lofty valuation compared to Invitae?
Via
The Motley Fool
Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply
December 16, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday.
Via
Benzinga
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain
December 16, 2022
The broader market lost more ground on Friday.
Via
The Motley Fool
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Via
Benzinga
COSM Stock Alert: What to Know As Cosmos’ Reverse Stock Split Takes Effect
December 16, 2022
Cosmos (COSM) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today.
Via
InvestorPlace
Scholastic, Maxar Technologies And Some Other Big Stocks Moving Higher On Friday
December 16, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy?
December 16, 2022
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.
Via
InvestorPlace
Why Is Exact Sciences (EXAS) Stock Up 23% Today?
December 16, 2022
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.
Via
InvestorPlace
Dow Drops 200 Points; Accenture Posts Upbeat Results
December 16, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.
Via
Benzinga
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
Cathie Wood Adds Another $1M In Tesla After Elon Musk's Stock Sale
December 15, 2022
Cathie Wood-led ARK Investment Management continued to buy Tesla Inc (NASDAQ: TSLA) shares on Thursday with the funds purchasing over 6,000 shares of the EV maker at an estimated valuation of over $1...
Via
Benzinga
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
December 15, 2022
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.
Via
Investor's Business Daily
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
December 15, 2022
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.